|
|
| | 7H-Pyrrolo[2,3-d]pyridazin-7-one, 4-amino-3-[2-(2-cyclopropyl-5-benzoxazolyl)ethynyl]-1,6-dihydro-1-[(3S)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]- Basic information |
| | 7H-Pyrrolo[2,3-d]pyridazin-7-one, 4-amino-3-[2-(2-cyclopropyl-5-benzoxazolyl)ethynyl]-1,6-dihydro-1-[(3S)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]- Chemical Properties |
| density | 1.53±0.1 g/cm3(Predicted) | | pka | 12.28±0.40(Predicted) |
| | 7H-Pyrrolo[2,3-d]pyridazin-7-one, 4-amino-3-[2-(2-cyclopropyl-5-benzoxazolyl)ethynyl]-1,6-dihydro-1-[(3S)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]- Usage And Synthesis |
| Uses | FGFR-IN-5 is a potent inhibitor of FGFR. Fibroblast growth factor receptor (FGFR) is a tyrosine kinase receptor that binds to fibroblast growth factor ligands. FGFR-IN-5 has the potential for the research of cancer diseases (extracted from patent WO2022042612A1, compound 3)[1]. FGFR-IN-5 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | | References | [1] Haibin Deng, et al. Dihydropyrrolo[2,3-d]pyridazin-7-one derivative, preparation method therefor, and application thereof. Patent WO2022042612A1. |
| | 7H-Pyrrolo[2,3-d]pyridazin-7-one, 4-amino-3-[2-(2-cyclopropyl-5-benzoxazolyl)ethynyl]-1,6-dihydro-1-[(3S)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]- Preparation Products And Raw materials |
|